AstraZeneca Pharma India
₹5,328.45
13.7 (0.26%)
29 March, 2024 13:22 BSE: 506820
NSE: ASTRAZENISIN: INE203A01020
Start SIP in AstraZeneca Pharma India
Start SIPAstrazeneca Pharma India Performance
Day Range
- Low 5,255
- High 5,380
52 Week Range
- Low 3,098
- High 7,221
- Open Price5,330
- Previous Close5,315
- Volume7994
AstraZeneca Pharma India Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 306 | 311 | 295 | 285 |
Operating Expenses Qtr Cr | 291 | 258 | 228 | 225 |
Operating Profit Qtr Cr | 15 | 53 | 67 | 60 |
Depreciation Qtr Cr | 4 | 4 | 4 | 4 |
Interest Qtr Cr | 1 | 1 | 0 | 0 |
Tax Qtr Cr | 5 | 21 | 18 | 6 |
Net Profit Qtr Cr | 16 | 52 | 54 | 17 |
Astrazeneca Pharma India Technicals
EMA & SMA
Current Price
₹5,328.45
13.7 (0.26%)
- Bullish Moving Average
- ___
- 12
- Bearish Moving Average
- ___
- 4
- 20 Day
- ₹5,263.08
- 50 Day
- ₹5,432.60
- 100 Day
- ₹5,310.69
- 200 Day
- ₹4,880.48
- 20 Day
- ₹5,242.67
- 50 Day
- ₹5,710.12
- 100 Day
- ₹5,398.37
- 200 Day
- ₹4,774.82
Astrazeneca Pharma India Resistance and Support
PIVOT
₹5,321.15
Resistance | |
---|---|
First Resistance | 5,387.30 |
Second Resistance | 5,446.15 |
Third Resistance | 5,512.30 |
RSI | 50.01 |
MFI | 48.31 |
MACD Single Line | -162.00 |
MACD | -122.93 |
Support | |
---|---|
First Resistance | 5,262.30 |
Second Resistance | 5,196.15 |
Third Resistance | 5,137.30 |
Astrazeneca Pharma India Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 9,003 | 374,615 | 41.61 |
Week | 16,699 | 694,825 | 41.61 |
1 Month | 15,198 | 873,907 | 57.5 |
6 Month | 27,775 | 856,592 | 30.84 |
Astrazeneca Pharma India Result Highlights
AstraZeneca Pharma India Synopsis
NSE-Medical-Diversified
Astrazeneca Pharma I is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1002.97 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2023. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.Market Cap | 13,321 |
Sales | 1,197 |
Shares in Float | 0.63 |
No of funds | 97 |
Yield | 0.3 |
Book Value | 22.63 |
U/D Vol ratio | 0.7 |
LTDebt / Equity | |
Alpha | 0.14 |
Beta | 0.67 |
AstraZeneca Pharma India
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 75% | 75% | 75% | 75% |
Mutual Funds | 2.75% | 2.42% | 1.76% | 1.22% |
Foreign Portfolio Investors | 2.66% | 2.69% | 2.68% | 2.7% |
Financial Institutions/ Banks | ||||
Individual Investors | 17.09% | 17.44% | 18.12% | 18.46% |
Others | 2.5% | 2.45% | 2.44% | 2.62% |
AstraZeneca Pharma India Management
Name | Designation |
---|---|
Mr. Narayan K Seshadri | Chairman & Ind.Director |
Mr. Sanjeev Kumar Panchal | Executive Director |
Mr. Rajesh Marwaha | Executive Director |
Mr. Ankush Nandra | Non Executive Director |
Ms. Shilpa Shidhar Divekar | Independent Director |
Ms. Weiying Sarah Wang | Non Executive Director |
Ms. Revathy Ashok | Independent Director |
Astrazeneca Pharma India Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Astrazeneca Pharma India Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | Quarterly Results | |
2023-11-09 | Quarterly Results | |
2023-08-14 | Quarterly Results | |
2023-05-30 | Audited Results & Dividend | |
2023-02-10 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-07-14 | FINAL | Rs.16.00 per share(800%)Dividend |
2022-07-08 | FINAL | Rs.8.00 per share(400%)Final Dividend |
2021-08-20 | INTERIM | Rs.2.00 per share(100%)Interim Dividend |
AstraZeneca Pharma India FAQs
What is Share Price of AstraZeneca Pharma India ?
AstraZeneca Pharma India share price is ₹5,328 As on 29 March, 2024 | 13:08
What is the Market Cap of AstraZeneca Pharma India ?
The Market Cap of AstraZeneca Pharma India is ₹13321.1 Cr As on 29 March, 2024 | 13:08
What is the P/E ratio of AstraZeneca Pharma India ?
The P/E ratio of AstraZeneca Pharma India is 95.6 As on 29 March, 2024 | 13:08
What is the PB ratio of AstraZeneca Pharma India ?
The PB ratio of AstraZeneca Pharma India is 22.6 As on 29 March, 2024 | 13:08